A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population

Clinical Endocrinology

Volumn 79, Issue 6, 2013, Pages 874-881

  Santos Palacios, Silvia ^a   Brugos Larumbe, Antonio ^b   Guillén Grima, Francisco ^a   Galofré, Juan C ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; EZETIMIBE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; THYROTROPIN; TRIACYLGLYCEROL; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD; SEX DIFFERENCE; SMOKING; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; BLOOD; COMPLICATION; DYSLIPIDEMIAS; HYPOTHYROIDISM; MIDDLE AGED; SPAIN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPOTHYROIDISM; LIPIDS; MALE; MIDDLE AGED; REFERENCE VALUES; SPAIN; THYROTROPIN; THYROXINE; TRIGLYCERIDES;

EID: 84887471662     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12216     Document Type: Article

References (34)

1. Choi, J.W., &, Choi, H.S., (2000) The regulatory effects of thyroid hormone on the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Endocrine Research, 26, 1-21. (Pubitemid 30123797)
2. Duntas, L.H., (2002) Thyroid disease and lipids. Thyroid, 12, 287-293. (Pubitemid 34438931)
3. Asvold, B.O., Vatten, L.J., Nilsen, T.I., et al,. (2007) The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. European Journal of Endocrinology, 156, 181-186. (Pubitemid 46554512)
4. Vierhapper, H., Nardi, A., Grösser, P., et al,. (2000) Low-density lipoprotein cholesterol in subclinical hypothyroidism. Thyroid, 10, 981-984. (Pubitemid 32104085)
5. Boekholdt, S.M., Titan, S.M., Wiersinga, W.M., et al,. (2010) Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clinical Endocrinology, 72, 404-410.
6. Biondi, B., &, Klein, I., (2004) Hypothyroidism as a risk factor for cardiovascular disease. Endocrine, 24, 1-13. (Pubitemid 41364165)
7. Pearce, E.N., (2012) Update in lipid alterations in subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 97, 326-333.
8. Danese, M.D., Ladenson, P.W., Meinert, C.L., et al,. (2000) Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. Journal of Clinical Endocrinology and Metabolism, 85, 2993-3001.
9. Hueston, W.J., &, Pearson, W.S., (2004) Subclinical hypothyroidism and the risk of hypercholesterolemia. Annals of Family Medicine, 2, 351-355. (Pubitemid 39107893)
10. Sawin, C.T., Castelli, W.P., Hershman, J.M., et al,. (1985) The aging thyroid. Thyroid deficiency in the Framingham Study. Archives of Internal Medicine, 145, 1386-1388. (Pubitemid 15049789)
11. Galofré, J.C., Frühbeck, G., &, Salvador, J., (2010) Obesity and thyroid function: pathophysiological and therapeutic implications. Hot Thyroidology, 6, 1-22. Available at: http://www.hotthyroidology.com/ editorial-214.html, accessed 9 April 2013.
12. Galofré, J.C., Pujante, P., Abreu, C., et al,. (2008) Relationship between TSH and insulin in euthyroid obese men. Annals of Nutrition and Metabolism, 53, 188-194.
13. Garduño-Garcia Jde J, Alvirde-Garcia, U., López-Carrasco, G., et al,. (2010) TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. European Journal of Endocrinology, 163, 273-278.
14. Lu, L., Wang, B., Shan, Z., et al,. (2011) The correlation between thyrotropin and dyslipidaemia in a population-based study. Journal of Korean Medical Science, 26, 243-249.
15. Spencer, C.A., Hollowell, J.G., Kazarosyan, M., et al,. (2007) National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. Journal of Clinical Endocrinology and Metabolism, 92, 4236-4240. (Pubitemid 350074737)
16. Surks, M.I., &, Boucai, L., (2010) Age- and race-based serum thyrotropin reference limits. Journal of Clinical Endocrinology and Metabolism, 95, 496-502.
17. Atzmon, G., Barzilai, N., Hollowell, J.G., et al,. (2009) Extreme longevity is associated with increased serum thyrotropin. Journal of Clinical Endocrinology and Metabolism, 94, 1251-1254.
18. Duntas, L.H., &, Brenta, G., (2012) The effect of thyroid disorders on lipid levels and metabolism. Medical Clinics of North America, 96, 269-281.
19. Canaris, G.J., Manowitz, N.R., Mayor, G., et al,. (2000) The Colorado thyroid disease prevalence study. Archives of Internal Medicine, 160, 526-534. (Pubitemid 30112276)
20. Wang, F., Tan, Y., Wang, C., et al,. (2012) Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones. Journal of Clinical Endocrinology and Metabolism, 97, 2724-2731.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
22. Bakker, S.J., ter Maaten, J.C., Popp-Snijders, C., et al,. (2001) The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. Journal of Clinical Endocrinology and Metabolism, 86, 1206-1211. (Pubitemid 32323006)
23. Nikkilä, E.A., &, Kekki, M., (1972) Plasma triglyceride metabolism in thyroid disease. Journal of Clinical Investigation, 51, 2103-2114.
24. Clark, P.M., Holder, R.L., Haque, S.M., et al,. (2012) The relationship between serum TSH and free T4 in older people. Journal of Clinical Pathology, 65, 463-465.
25. Tunbridge, W.M., Evered, D.C., Hall, R., et al,. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology, 7, 481-493. (Pubitemid 8235965)
26. Lee, Y.K., Kim, J.E., Oh, H.J., et al,. (2011) Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean Journal of Internal Medicine, 26, 432-439.
27. Iacobellis, G., Ribaudo, M.C., Zappaterreno, A., et al,. (2005) Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clinical Endocrinology, 62, 487-491.
28. Chubb, S.A., Davis, W.A., &, Davis, T.M., (2005) Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. Journal of Clinical Endocrinology and Metabolism, 90, 5317-5320. (Pubitemid 41262293)
29. Asvold, B.O., BjÃro, T., Nilsen, T.I., et al,. (2007) Tobacco smoking and thyroid function: a population-based study. Archives of Internal Medicine, 167, 1428-1432. (Pubitemid 47052443)
30. Baloch, Z., Carayon, P., Conte-Devoix, B., et al,. (2003) Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 13, 3-126.
31. Kratzsch, J., Fiedler, G.M., Leichtle, A., et al,. (2005) New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clinical Chemistry, 51, 1480-1486. (Pubitemid 41060881)
32. Baskin, H.J., Cobin, R.H., Duick, D.S., et al,. (2002) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation of treatment of hyperthyroidism and hypothyroidism. Endocrine Practice, 8, 457-469.
33. Wartofsky, L., &, Dickey, R.A., (2005) Controversy in clinical endocrinology: the evidence for a narrower thyrotropin reference range is compelling. Journal of Clinical Endocrinology and Metabolism, 90, 5483-5488. (Pubitemid 41262320)
34. Surks, M.I., Goswami, G., &, Daniels, G.H., (2005) Controversy in clinical endocrinology: the thyrotropin reference range should remain unchanged. Journal of Clinical Endocrinology and Metabolism, 90, 5489-5496. (Pubitemid 41262321)